Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Dupixent (dupilumab)

Indications: atopic dermatitis

Call For Patient Input: September 23, 2019

Patient Input Closed: November 12, 2019

Entyvio (vedolizumab)

Indications: Ulcerative Colitis

Call For Patient Input: September 19, 2019

Patient Input Closed: November 8, 2019

Jorveza (budesonide)

Indications: Eosinophilic esophagitis, adults.

Call For Patient Input: September 3, 2019

Patient Input Closed: October 23, 2019